In addition to this conclusion, our finding that the forced expression of ATAD2 increases the sensitivity of hypoxic cancer cells to anticancer drugs justifies the development of a novel strategy to inhibit the reduction in ATAD2 protein to sensitize hypoxic tumor cells to chemotherapy (Figure 3). Here, ATAD2 is linked to cancer.